AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22669229 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal hand hygiene improvement strategy (training sessions, hydroalcoholic solutions, reminder posters)
Number of subjects: 198
Study 22669229 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 198
Study 21290360 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation session (n=26), 30-minute hands-on session
Number of subjects: 50
Study 21290360 — intervention group
Group type: COMPARATOR
Intervention: Image-based interactive lecture (n=24), 30-minute session
Number of subjects: 50
Study 21290360 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation session (n=26)
Number of subjects: 50
Study 18044562 — intervention group
Group type: EXPERIMENTAL
Intervention: Discriminative model based on fMRI and anatomical template
Number of subjects: 83
Study 18044562 — intervention group
Group type: COMPARATOR
Intervention: Anatomical parcellation process
Number of subjects: 83
Study 15954910 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting somatostatin (octreotide-LAR, 40 mg intramuscularly every 28 days)
Number of subjects: 12
Study 15954910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 12410487 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (GH) at a dose of 0.1 mg/kg/day
Number of subjects: 0
Study 12410487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11030804 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (50 mg)
Number of subjects: 28519
Study 11030804 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta carotene supplementation (20 mg)
Number of subjects: 28519
Study 11030804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28519
Study 8835043 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin (Trimox)
Number of subjects: 30
Study 8835043 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin (Amoxil)
Number of subjects: 30
Study 8835043 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin VK (V-Cillin-K)
Number of subjects: 30
Study 8835043 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin VK (PenVee K)
Number of subjects: 30
Study 8835043 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin VK (VeeTids)
Number of subjects: 30
Study 8835043 — intervention group
Group type: COMPARATOR
Intervention: Penicillin VK (overall)
Number of subjects: 30
Study 1568570 — intervention group
Group type: COMPARATOR
Intervention: NSAID + placebo
Number of subjects: 20
Study 1568570 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID + misoprostol
Number of subjects: 20
Study 1568570 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol alone
Number of subjects: 20
Study 3858912 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mug PGEsub 1‐carbinol
Number of subjects: 15
Study 3858912 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mug PGEsub 1‐carbinol
Number of subjects: 15
Study 3858912 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mug PGEsub 1‐carbinol
Number of subjects: 15
Study 3858912 — intervention group
Group type: EXPERIMENTAL
Intervention: 55 mug PGEsub 2
Number of subjects: 15
Study 3858912 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10% ethanol in normal saline)
Number of subjects: 15
Study 3858912 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mug fenoterol
Number of subjects: 15
Study 31953303 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (0.05 mg/kg twice daily)
Number of subjects: 50
Study 31953303 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone (1 mg/kg daily up to 60 mg daily)
Number of subjects: 50
Study 31640110 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Play!
Number of subjects: 97
Study 31640110 — intervention group
Group type: EXPERIMENTAL
Intervention: Outdoor Play!
Number of subjects: 97
Study 28931411 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (100 mg per day as add-on therapy to antipsychotics)
Number of subjects: 90
Study 28931411 — intervention group
Group type: COMPARATOR
Intervention: Placebo (treatment as usual with antipsychotics)
Number of subjects: 90
Study 26167680 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized-protocol with adjusted injection rate based on patient weight and contrast medium concentration (280 mgI/kg)
Number of subjects: 160
Study 26167680 — intervention group
Group type: COMPARATOR
Intervention: Conventional contrast injection protocol with total injection volume of 80ml and constant injection rate of 5.5ml/s
Number of subjects: 160
Study 26167680 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized-protocol
Number of subjects: 160
Study 23978513 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory TBS
Number of subjects: 12
Study 23978513 — intervention group
Group type: COMPARATOR
Intervention: Sham TBS
Number of subjects: 12
Study 21519151 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blockade with metoprolol (up to 50mg b.i.d.) or carvedilol (up to 25mg b.i.d.)
Number of subjects: 21
Study 21519151 — intervention group
Group type: COMPARATOR
Intervention: Control (ACE inhibitor treatment without β-blockade)
Number of subjects: 21
Study 18482349 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer crowns with a glass-fibre framework (group 1)
Number of subjects: 120
Study 18482349 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer crowns without framework stabilization (group 2)
Number of subjects: 120
Study 18482349 — intervention group
Group type: COMPARATOR
Intervention: Metal-ceramic crowns (control group)
Number of subjects: 120
Study 16413644 — intervention group
Group type: EXPERIMENTAL
Intervention: Meaning-making intervention (up to four sessions exploring emotional responses and cognitive appraisals)
Number of subjects: 82
Study 16413644 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 82
Study 12616233 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-arch impression technique
Number of subjects: 50
Study 12616233 — intervention group
Group type: COMPARATOR
Intervention: Complete-arch impression technique
Number of subjects: 50
Study 10714475 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day moxifloxacin 400 mg once daily
Number of subjects: 936
Study 10714475 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day moxifloxacin 400 mg once daily
Number of subjects: 936
Study 10714475 — intervention group
Group type: COMPARATOR
Intervention: 10-day clarithromycin 500 mg bid
Number of subjects: 936
Study 9257090 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligoantigenic diet
Number of subjects: 49
Study 9257090 — intervention group
Group type: COMPARATOR
Intervention: Methylphenidate
Number of subjects: 49
Study 9257090 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (Oligoantigenic diet and Methylphenidate)
Number of subjects: 49
Study 8299614 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (400 mg)
Number of subjects: 24
Study 8299614 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (400 mg)
Number of subjects: 24
Study 8299614 — intervention group
Group type: COMPARATOR
Intervention: Placebo (400 mg)
Number of subjects: 24
Study 3829298 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane (ISO)
Number of subjects: 16
Study 3829298 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 16
Study 31741148 — intervention group
Group type: EXPERIMENTAL
Intervention: Navilas laser
Number of subjects: 70
Study 31741148 — intervention group
Group type: COMPARATOR
Intervention: Conventional single-spot laser
Number of subjects: 70
Study 29461660 — intervention group
Group type: EXPERIMENTAL
Intervention: Belatacept (more intense-based)
Number of subjects: 1209
Study 29461660 — intervention group
Group type: EXPERIMENTAL
Intervention: Belatacept (less intense-based)
Number of subjects: 1209
Study 29461660 — intervention group
Group type: EXPERIMENTAL
Intervention: Belatacept
Number of subjects: 1209
Study 29461660 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 1209
Study 29461660 — intervention group
Group type: EXPERIMENTAL
Intervention: Belatacept (black patients)
Number of subjects: 1209
Study 29461660 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (black patients)
Number of subjects: 1209
Study 29461660 — intervention group
Group type: EXPERIMENTAL
Intervention: Belatacept and Cyclosporine
Number of subjects: 1209
Study 29178932 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbst appliance with dental anchorage
Number of subjects: 0
Study 29178932 — intervention group
Group type: COMPARATOR
Intervention: Herbst appliance with skeletal anchorage
Number of subjects: 0
Study 25637849 — intervention group
Group type: EXPERIMENTAL
Intervention: MiniArc
Number of subjects: 225
Study 25637849 — intervention group
Group type: COMPARATOR
Intervention: Monarc
Number of subjects: 225
Study 21652093 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 883
Study 21652093 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol
Number of subjects: 883
Study 21652093 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rated health (SRH) assessment
Number of subjects: 883
Study 20861065 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror condition (observing mirror reflection of the unaffected hand)
Number of subjects: 22
Study 20861065 — intervention group
Group type: COMPARATOR
Intervention: No-mirror condition (observing affected hand directly)
Number of subjects: 22
Study 18801303 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg/kg initial dose followed by 0.15 mg/kg repeated doses
Number of subjects: 60
Study 18801303 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.15 mg/kg repeated doses
Number of subjects: 60
Study 18801303 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 60
Study 17201213 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroimpulse therapy
Number of subjects: 0
Study 14733347 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthotripsy (extracorporeal shock waves)
Number of subjects: 0
Study 14733347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14733347 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthotripsy (after crossover from placebo)
Number of subjects: 0
Study 14733347 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthotripsy (for patients with longest symptom duration)
Number of subjects: 0
Study 10878703 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete androgen deprivation
Number of subjects: 24
Study 10878703 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 24
Study 9366716 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunonutrition group (n = 87)
Number of subjects: 260
Study 9366716 — intervention group
Group type: COMPARATOR
Intervention: Standard group (n = 87)
Number of subjects: 260
Study 9366716 — intervention group
Group type: COMPARATOR
Intervention: Parenteral group (n = 86)
Number of subjects: 260
Study 8040780 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula A (3.0 gm/100 kcal)
Number of subjects: 27
Study 8040780 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula B (2.7 gm/100 kcal)
Number of subjects: 27
Study 8040780 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula C (2.2 gm/100 kcal)
Number of subjects: 27
Study 2737225 — intervention group
Group type: EXPERIMENTAL
Intervention: Alifedrine 40 mg
Number of subjects: 30
Study 2737225 — intervention group
Group type: EXPERIMENTAL
Intervention: Alifedrine 50 mg
Number of subjects: 30
Study 2737225 — intervention group
Group type: EXPERIMENTAL
Intervention: Alifedrine 60 mg
Number of subjects: 30
Study 2737225 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 31139998 — intervention group
Group type: EXPERIMENTAL
Intervention: First-person perspective e-learning videos
Number of subjects: 91
Study 31139998 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic view only e-learning videos
Number of subjects: 91
Study 30958065 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse Oximetry (PO)
Number of subjects: 94
Study 30958065 — intervention group
Group type: COMPARATOR
Intervention: Doppler Ultrasound (DU)
Number of subjects: 94
Study 28151719 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide (enza)
Number of subjects: 48
Study 28151719 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide + Dutasteride + LHRHa (enza/dut/LHRHa)
Number of subjects: 48
Study 27132448 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 90
Study 27132448 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 90
Study 27132448 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 90
Study 22903362 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate gymnastics training programme
Number of subjects: 53
Study 22903362 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study 21063431 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil concentrate with EPA+DHA (1.01g+0.67g) as reesterified triacylglycerides (rTAG group)
Number of subjects: 150
Study 21063431 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil concentrate with EPA+DHA (1.01g+0.67g) as ethyl ester (EE group)
Number of subjects: 150
Study 21063431 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (placebo group)
Number of subjects: 150
Study 19305319 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasonography and CA 125 screening
Number of subjects: 34261
Study 19305319 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 34261
Study 17445351 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily consumption of 1440 kJ serving of almonds for 10 weeks
Number of subjects: 20
Study 17445351 — intervention group
Group type: COMPARATOR
Intervention: Customary diet for 10 weeks (control)
Number of subjects: 20
Study 17445351 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily consumption of almonds
Number of subjects: 20
Study 15239282 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux‐Y (n=18)
Number of subjects: 60
Study 15239282 — intervention group
Group type: COMPARATOR
Intervention: Billroth I (n=25)
Number of subjects: 60
Study 15239282 — intervention group
Group type: COMPARATOR
Intervention: Billroth II (n=17)
Number of subjects: 60
Study 11590218 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm oil
Number of subjects: 10
Study 11590218 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesterified palm oil
Number of subjects: 10
Study 9671372 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned media from isolated human mononuclear cells
Number of subjects: 0
Study 9671372 — intervention group
Group type: COMPARATOR
Intervention: Control media
Number of subjects: 0
Study 9671372 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimethylphenylpiperazinium (10 microM)
Number of subjects: 0
Study 9671372 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned media from mixed leukocyte reaction
Number of subjects: 0
Study 9671372 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone pretreatment
Number of subjects: 0
Study 9671372 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokines IL-1 and IL-2 (50 and 500 units/well)
Number of subjects: 0
Study 7672677 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg twice daily plus amoxicillin 1 g twice daily
Number of subjects: 50
Study 7672677 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 40 mg twice daily plus amoxicillin 1 g twice daily
Number of subjects: 50
Study 2376846 — intervention group
Group type: EXPERIMENTAL
Intervention: Repressive coping style
Number of subjects: 120
Study 7211811 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 61
Study 7211811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 31387417 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 695501 (Group A)
Number of subjects: 430
Study 31387417 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 695501 (Group B)
Number of subjects: 430
Study 31387417 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab RP (Group C)
Number of subjects: 430
Study 28506150 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast movement training (420 repetitions/day)
Number of subjects: 36
Study 28506150 — intervention group
Group type: COMPARATOR
Intervention: Slow movement training (420 repetitions/day)
Number of subjects: 36
Study 25752740 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib
Number of subjects: 3074
Study 25752740 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3074
Study 23636199 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual simulator
Number of subjects: 22
Study 23636199 — intervention group
Group type: COMPARATOR
Intervention: Sawbones simulator
Number of subjects: 22
Study 22194814 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded calf compression stockings
Number of subjects: 15
Study 22194814 — intervention group
Group type: COMPARATOR
Intervention: Calf placebo stockings
Number of subjects: 15
Study 22194814 — intervention group
Group type: COMPARATOR
Intervention: Ankle placebo stockings
Number of subjects: 15
Study 19482879 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening SMS intervention
Number of subjects: 70
Study 19482879 — intervention group
Group type: COMPARATOR
Intervention: No evening SMS intervention (Control)
Number of subjects: 70
Study 17037995 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs); duration 8-16 weeks.
Number of subjects: 344
Study 17037995 — intervention group
Group type: COMPARATOR
Intervention: Placebo; duration 8-16 weeks.
Number of subjects: 344
Study 12632615 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid preloading (6% hydroxyethyl starch; HES) at 8 ml.kg‐1 before spinal anesthesia
Number of subjects: 20
Study 12632615 — intervention group
Group type: COMPARATOR
Intervention: No prehydration (Control group)
Number of subjects: 20
Study 11013810 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative antibiotic prophylaxis (PAP) as per the quality standard developed in 1994.
Number of subjects: 0
Study 11013810 — intervention group
Group type: EXPERIMENTAL
Intervention: New randomized controlled studies on PAP.
Number of subjects: 0
Study 1678643 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g of oral calcium supplementation/day for three months postoperatively
Number of subjects: 16
Study 1678643 — intervention group
Group type: COMPARATOR
Intervention: Control (no calcium supplementation)
Number of subjects: 16
Study 6605501 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmentin
Number of subjects: 52
Study 6605501 — intervention group
Group type: COMPARATOR
Intervention: Co-trimoxazole
Number of subjects: 52
Study 30795773 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole monotherapy
Number of subjects: 3021
Study 30795773 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen monotherapy
Number of subjects: 3021
Study 30795773 — intervention group
Group type: EXPERIMENTAL
Intervention: AR expression
Number of subjects: 3021
Study 29458517 — intervention group
Group type: EXPERIMENTAL
Intervention: Text warning labels
Number of subjects: 1200
Study 29458517 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial warning labels
Number of subjects: 1200
Study 29458517 — intervention group
Group type: COMPARATOR
Intervention: Control group (water bottle labels)
Number of subjects: 1200
Study 26376936 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual history taking based on the ars moriendi model
Number of subjects: 49
Study 26376936 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 49
Study 25294589 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban 30 mg once daily
Number of subjects: 716
Study 25294589 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin 2000 IU subcutaneously twice daily
Number of subjects: 716
Study 25294589 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 716
Study 25294589 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 716
Study 22516508 — intervention group
Group type: EXPERIMENTAL
Intervention: LEV XR 2000 mg/day
Number of subjects: 228
Study 22516508 — intervention group
Group type: EXPERIMENTAL
Intervention: LEV XR 1000 mg/day
Number of subjects: 228
Study 22516508 — intervention group
Group type: COMPARATOR
Intervention: Historical control
Number of subjects: 228
Study 20353031 — intervention group
Group type: EXPERIMENTAL
Intervention: Zishen Shengxue Recipe (ZSR) combined with subcutaneous injection of erythropoiesis stimulating factor (rHuEpo)
Number of subjects: 60
Study 20353031 — intervention group
Group type: COMPARATOR
Intervention: Control group treated with rHuEpo alone
Number of subjects: 60
Study 17569144 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasojejunal enteral nutrition with prebiotic fiber supplementation
Number of subjects: 30
Study 17569144 — intervention group
Group type: COMPARATOR
Intervention: Standard enteral nutrition
Number of subjects: 30
Study 16144070 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-reducing visco-elastic foam mattress (Pressurease)
Number of subjects: 21
Study 12153828 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medication (tricyclic antidepressants and phenelzine)
Number of subjects: 883
Study 12153828 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy (primarily cognitive behavior and interpersonal therapies)
Number of subjects: 883
Study 12153828 — intervention group
Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 883
Study 12153828 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 883
Study 12153828 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 883
Study 10511772 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum Cu concentrations in patients with pulmonary diseases
Number of subjects: 118
Study 10511772 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum Cu concentrations in patients with malignant diseases
Number of subjects: 118
Study 10511772 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum Cu concentrations in patients with cardiovascular diseases
Number of subjects: 118